Healthy Living/WellnessPrice Of Drug For Infants With Rare Epilepsy Jumps By 2000 Percent Infantile spasm drug Synacthen Depot cost-per-vial jumped by 2,000 percent. The sudden price hike caused Alberta Health to delist the drug in the government-subsidized healthcare and many health officials and families affected.by Katherine Derla
Healthy Living/WellnessDrinking Coffee Everyday Linked To Reduced Death Risk From Heart Disease, Diabetes And Suicideby Rhodi Lee
Healthy Living/WellnessGenetic Tests Establish How Exposure To Sunlight Mutates Moles To Melanomaby Angela Laguipo
Healthy Living/WellnessWHO Warns Of Dangerously High Levels Of Antibiotic Resistance Worldwide: What Drives Surge Of Superbugs?by Katrina Pascual
Healthy Living/WellnessImplantable Artificial Kidney May Soon Offer Economical Alternative To Dialysis And Organ Transplant: How It Worksby Katherine Derla
Healthy Living/WellnessFeeling Dizzy While Scrolling Your Smartphone? It Could Be Cybersicknessby Katherine Derla
Healthy Living/WellnessScientists Develop Medical Dressing That Changes Color When It Detects Infectionby Alyssa Navarro
Healthy Living/WellnessHealthy Breakfast Linked To Better School Results: Best Foods To Boost Academic Performanceby Katherine Derla
Healthy Living/WellnessScientists Breed Beagles With Muscular Dystrophy To Develop Drugs For Deadly Diseaseby Alyssa Navarro
Healthy Living/WellnessType 2 Diabetes Can Affect Children As Young As 9: Symptoms Parents Should Watch Out Forby Rina Marie Doctor
Healthy Living/WellnessUN Launches World Toilet Day: 2.4 Billion People Worldwide Lack Access To Decent Sanitationby Rina Marie Doctor